By Michael Szkarlat, Partner Development Director
Dry eye is a common condition affecting millions of people globally. While standard treatments for dry eye exist, what can be done when standard treatments don’t work?
In the April 2023 edition of Eversight's Webinar Series, Mark Milner, MD of Golden Eye in Palm Beach Florida - an expert in cornea and dry eye - discusses innovative dry eye therapies that can supplement standard options. These can be divided into five categories: compounded medications, biologics, neurostimulation, immunosuppression, and anti-infectives.
Dr. Milner finishes with a brief overview of the innovative treatments that may be available in the future or are currently in development. Overall, it is important to remember that dry eye is a complex disease and there is no one-size-fits-all treatment for patients. In fact, dry eye is most often a multi-treatment disease.
The webinar ends with a spirited question-and-answer session that highlights some great tips for both online and compounding pharmacies. Check out the resources below!
Dry Eye Treatment Algorithm: Dr. Milner’s algorithm for the treatment of dry eye is published, free and available here.
- Scripthero: mentioned by Dr. Milner as a way to get discounted Cequa in cases where it is being used in combination with Restasis and therefore not covered for the patient.
- VLS Pharmacy: Dr. Milner recommends using this pharmacy for a variety of compounded medications.
Eversight's free webinars are a great way for you to connect, learn and train digitally with leading ophthalmologists and researchers from around the world. We invite you to RSVP for scheduled webinars and browse our recording library.
Have an idea for a future topic? Interested in receiving timely and relevant information from Eversight? We'd love to hear from you!
Share this Post
About the author
Michael Szkarlat, Partner Development Director
Michael has been with Eversight since 2016 and has recently worked to develop Eversight's educational wet lab programs for EK surgery and a standardized protocol for DALK practice in a wet lab setting. His eye banking experience is rooted in the preparation of corneal grafts and spent nearly five years as Eversight’s Medical Director designee in charge of training clinical team members to prepare corneal tissue for DMEK and DSAEK surgery. In his time at Eversight, Michael has presented at scientific conferences, been involved in clinical research and developed innovations in tissue processing. He was named an IAPB Eye Heath Hero in the innovations category. Michael is passionate about community-based eye banking and honoring the precious gift that is donation. When not at work, he enjoys traveling with his wife and baking artisan sourdough bread.
